GCKR and metabolic dysfunction-associated steatotic liver disease: SNPs in other genes, including TM6SF2 (Trans-Membrane 6 Super-Family member 2) rs58542926 on 19p13.11 (Modulate hepatic VLDL secretion (Very-Low-Density Lipoprotein), GCKR (Glucokinase Regulator) rs780094 on 2p23.3 (Modulate hepatic lipogenesis), MBOAT7 (Membrane Bound O-Acyl Transferase domain containing 7) rs641738 on 19q13.42 (Remodeling of phosphatidylinositol), and HSD17B13 (Hydroxy-Steroid 17-beta dehydrogenase 13) rs72613567: TA on 4q22.1 (Retinol dehydrogenase activity) have been associated with NAFLD development and/or progression.